Thomas Mulligan

Summary

Country: USA

Publications

  1. ncbi request reprint Disorders of male sexual function
    Thomas Mulligan
    Virginia Commonwealth University School of Medicine, McGuire Veterans Affairs Medical Center, Richmond, VA, USA
    Clin Geriatr Med 19:473-81, v. 2003
  2. pmc Prevalence of hypogonadism in males aged at least 45 years: the HIM study
    T Mulligan
    Division of Geriatrics, Malcom Randall VAMC GRECC and University of Florida, Gainesville, FL 32608, USA
    Int J Clin Pract 60:762-9. 2006
  3. ncbi request reprint A trial study: the effect of low dose human chorionic gonadotropin on the symptoms of benign prostatic hyperplasia
    Michael F Godschalk
    Virginia Commonwealth University School of Medicine, Richmond, USA
    J Urol 170:1264-9. 2003
  4. pmc Testosterone replacement therapy for older men
    Stephen E Borst
    Geriatrics Research, Education, and Clinical Center, North Florida South Georgia Veterans Health System, Gainesville, FL, USA
    Clin Interv Aging 2:561-6. 2007
  5. ncbi request reprint Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study
    Michael S Okun
    Department of Neurology, University of Florida Movement Disorders Center, McKnight Brain Institute, Gainesville, FL 32610, USA
    Arch Neurol 63:729-35. 2006
  6. pmc Age and testosterone feedback jointly control the dose-dependent actions of gonadotropin-releasing hormone in healthy men
    Johannes D Veldhuis
    Division of Endocrinology and Metabolism, Mayo School of Graduate Medical Education, General Clinical Research Center, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 90:302-9. 2005
  7. ncbi request reprint Human immunodeficiency virus and hypogonadal bone disease
    Michael G Miller
    Medical Services Department, Solvay Pharmaceuticals, Inc, 2765 St Andrews Square, 1851, Allison Park, PA 15101, USA
    Pharmacotherapy 25:632-4; discussion 634. 2005
  8. ncbi request reprint Religiosity and self-rated health among Latin American and Caribbean elders
    Carlos A Reyes-Ortiz
    Sealy Center on Aging, University of Texas Medical Branch, Galveston, TX 77555 0460, USA
    Int J Psychiatry Med 37:425-43. 2007

Detail Information

Publications8

  1. ncbi request reprint Disorders of male sexual function
    Thomas Mulligan
    Virginia Commonwealth University School of Medicine, McGuire Veterans Affairs Medical Center, Richmond, VA, USA
    Clin Geriatr Med 19:473-81, v. 2003
    ..Therefore, preventive measures that are aimed at the underlying diseases should be sought. Nevertheless, effective treatment options are now available to successfully regain sexual function and thereby, improve quality of life...
  2. pmc Prevalence of hypogonadism in males aged at least 45 years: the HIM study
    T Mulligan
    Division of Geriatrics, Malcom Randall VAMC GRECC and University of Florida, Gainesville, FL 32608, USA
    Int J Clin Pract 60:762-9. 2006
    ..38), prostate disease (1.29) and asthma or chronic obstructive pulmonary disease (1.40) than in men without these conditions. The prevalence of hypogonadism was 38.7% in men aged > or = 45 years presenting to primary care offices...
  3. ncbi request reprint A trial study: the effect of low dose human chorionic gonadotropin on the symptoms of benign prostatic hyperplasia
    Michael F Godschalk
    Virginia Commonwealth University School of Medicine, Richmond, USA
    J Urol 170:1264-9. 2003
    ..Functionally HCG has a growth modulating effect on androgen independent prostate cell lines. We investigated the possible clinical effects of HCG on the symptoms associated with benign prostatic hyperplasia (BPH) in this trial study...
  4. pmc Testosterone replacement therapy for older men
    Stephen E Borst
    Geriatrics Research, Education, and Clinical Center, North Florida South Georgia Veterans Health System, Gainesville, FL, USA
    Clin Interv Aging 2:561-6. 2007
    ..Testosterone therapy produces a number of adverse effects, including worsening of sleep apnea, gynecomastia, polycythemia and elevation of PSA. Efficacy and adverse effects should be assessed frequently throughout the course of therapy...
  5. ncbi request reprint Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study
    Michael S Okun
    Department of Neurology, University of Florida Movement Disorders Center, McKnight Brain Institute, Gainesville, FL 32610, USA
    Arch Neurol 63:729-35. 2006
    ..Previously, we reported that testosterone deficiency is more common in patients with PD compared with age-matched control subjects, and we also reported in 2 small open-label studies that some nonmotor symptoms responded favorably to TT...
  6. pmc Age and testosterone feedback jointly control the dose-dependent actions of gonadotropin-releasing hormone in healthy men
    Johannes D Veldhuis
    Division of Endocrinology and Metabolism, Mayo School of Graduate Medical Education, General Clinical Research Center, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 90:302-9. 2005
    ..We conclude that a 3-fold interaction among GnRH dose, testosterone concentration, and age governs GnRH action, and age determines both testosterone-modulated and testosterone-independent actions of GnRH...
  7. ncbi request reprint Human immunodeficiency virus and hypogonadal bone disease
    Michael G Miller
    Medical Services Department, Solvay Pharmaceuticals, Inc, 2765 St Andrews Square, 1851, Allison Park, PA 15101, USA
    Pharmacotherapy 25:632-4; discussion 634. 2005
  8. ncbi request reprint Religiosity and self-rated health among Latin American and Caribbean elders
    Carlos A Reyes-Ortiz
    Sealy Center on Aging, University of Texas Medical Branch, Galveston, TX 77555 0460, USA
    Int J Psychiatry Med 37:425-43. 2007
    ..To describe religious affiliation, importance of religion, and the relationship between religion and self-rated health in persons aged 60 or older living in Latin America or the Caribbean...